Merkoša sitáhtat
APA-čujuhus (7. p.)
Teo, E., Lim, S. Y. J., Fong, S., Larbi, A., Wright, G. D., Tolwinski, N., & Gruber, J. (2020). A high throughput drug screening paradigm using transgenic Caenorhabditis elegans model of Alzheimer’s disease. KeAi Communications Co., Ltd.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Chicago-čujuhus (17. p.)
Teo, Emelyne, Soon Yew John Lim, Sheng Fong, Anis Larbi, Graham D. Wright, Nicholas Tolwinski, juo Jan Gruber. A High Throughput Drug Screening Paradigm Using Transgenic Caenorhabditis Elegans Model of Alzheimer’s Disease. KeAi Communications Co., Ltd, 2020.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
MLA-čujuhus (9. p.)
Teo, Emelyne, et al. A High Throughput Drug Screening Paradigm Using Transgenic Caenorhabditis Elegans Model of Alzheimer’s Disease. KeAi Communications Co., Ltd, 2020.
Kopierejuvvon čuohpusbeavdái
Kopieren čuohpusbeavdái ii lihkostuvvan
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.